-
1
-
-
79954456907
-
Surgical management after active surveillance for low-risk prostate cancer: Pathological outcomes compared with men undergoing immediate treatment
-
doi:10.1111/j.1464-410.X.2010.09589.x
-
Dall'era, M. A. et al. Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment. BJU Int. doi:10.1111/j.1464-410.X.2010.09589.x.
-
BJU Int.
-
-
Dall'Era, M.A.1
-
2
-
-
33645760008
-
Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology
-
Chun, F. K. et al. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology. Eur. Urol. 49, 820-826 (2006).
-
(2006)
Eur. Urol.
, vol.49
, pp. 820-826
-
-
Chun, F.K.1
-
3
-
-
78649362120
-
EaU guidelines on prostate cancer. part 1: Screening, diagnosis, and treatment of clinically localised disease
-
Heidenreich, A. et al. EaU guidelines on prostate cancer. part 1: screening, diagnosis, and treatment of clinically localised disease. Eur. Urol. 59, 61-71 (2011).
-
(2011)
Eur. Urol.
, vol.59
, pp. 61-71
-
-
Heidenreich, A.1
-
4
-
-
65049088199
-
Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer
-
Capitanio, U. et al. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer. Urology 73, 1087-1091 (2009).
-
(2009)
Urology
, vol.73
, pp. 1087-1091
-
-
Capitanio, U.1
-
5
-
-
56249097867
-
Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly
-
Van den Bergh, R. C. et al. Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly. Eur. Urol. 55, 1-8 (2009).
-
(2009)
Eur. Urol.
, vol.55
, pp. 1-8
-
-
Van Den Bergh, R.C.1
-
6
-
-
77952543434
-
Upgrading of Gleason score 6 prostate cancers on biopsy after prostatectomy in the low and intermediate tPSa range
-
Colleselli, D. et al. Upgrading of Gleason score 6 prostate cancers on biopsy after prostatectomy in the low and intermediate tPSa range. Prostate Cancer Prostatic Dis. 13, 182-185 (2010).
-
(2010)
Prostate Cancer Prostatic Dis.
, vol.13
, pp. 182-185
-
-
Colleselli, D.1
-
7
-
-
80052943704
-
Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: Results from a single institution series
-
doi:10.1016/j.urolonc.2009.07.003
-
Tilki, D. et al. Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series. Urol. Oncol. doi:10.1016/j.urolonc.2009.07.003.
-
Urol. Oncol.
-
-
Tilki, D.1
-
8
-
-
75149137443
-
A nomogram for predicting upgrading in patients with low-and intermediate-grade prostate cancer in the era of extended prostate sampling
-
Moussa, A. S. et al. A nomogram for predicting upgrading in patients with low-and intermediate-grade prostate cancer in the era of extended prostate sampling. BJU Int. 105, 352-358 (2010).
-
(2010)
BJU Int.
, vol.105
, pp. 352-358
-
-
Moussa, A.S.1
-
9
-
-
34250209140
-
Clinical predictors of gleason score upgrading: Implications for patients considering watchful waiting, active surveillance, or brachytherapy
-
DOI 10.1002/cncr.22712
-
Kulkarni, G. S. et al. Clinical predictors of Gleason score upgrading: implications for patient (Pubitemid 46906461)
-
(2007)
Cancer
, vol.109
, Issue.12
, pp. 2432-2438
-
-
Kulkarni, G.S.1
Lockwood, G.2
Evans, A.3
Toi, A.4
Trachtenberg, J.5
Jewett, M.A.S.6
Finelli, A.7
Fleshner, N.E.8
-
10
-
-
55749109028
-
Currently used criteria for active surveillance in men with low-risk prostate cancer: An analysis of pathologic features
-
Suardi, N. et al. Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features. Cancer 113, 2068-2072 (2008).
-
(2008)
Cancer
, vol.113
, pp. 2068-2072
-
-
Suardi, N.1
|